Overview
Status
Active
Registry date
2011-04-20
Share capital
10,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 1 of 5 financial statements was filed late (for 2021, 350 days late).
- 2023not filed
- 202230/06/2023
- 202130/06/2023
- 202002/04/2021
- 201928/03/2020
- 201826/06/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Voivodeship · Mazowieckie98,772 / 142,035
Top 70%
Country · Poland353,961 / 495,867
Top 71%
Results vs industry
Revenue
This companyUSD 33.29kMedianUSD 38.50kAverageUSD 150.26k
Net profit
This companyUSD 95.97MedianUSD 224.88AverageUSD 12.17k
Operating costs
This companyUSD 33.19kMedianUSD 38.91kAverageUSD 133.82k
Assets
This companyUSD 44.76kMedianUSD 17.01kAverageUSD 103.30k
Industry
Authorized Representatives
Katarzyna Piłat Nałęcz – President of the Management Board & Attorney-in-fact (sole)
Manner of representation
Each member of the management board is independently authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Martyna Stefania Nałęczage 25 | 10 | $270.12 | 10% |
Katarzyna Maria Piłat Nałęczage 54 | 90 | $2,431.12 | 90% |
Katarzyna Maria Piłat Nałęcz and Martyna Stefania Nałęcz hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cross Medica Szczepkowscysp. k. | $2,359,440.46 | crossmedica2.pl | ||
| Phtisp. z o.o. | $193,356.82 | maksymkomar.com | ||
| 21 Stópsp. z o.o. | $57,428.79 | architec.pl | ||
| Manuartissp. z o.o. | $50,092.92 | manuartis.pl | ||
| Namajasp. z o.o. | $33,511.51 | namaja.pl | ||
| Jedyne Zdrowiesp. z o.o. | $27,609.00 | jedynezdrowie.pl | ||
| Great Spiritsp. z o.o. | $14,713.90 | kemerling.pl | ||
| DR Art Clinic By Trychoestetykasp. z o.o. | $8,491.33 | drart.clinic | ||
| Holistic Housesp. z o.o. | $0.00 | holihouse.pl | ||
| Pillar Kloceksp. j. | – | pillar-pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-12-05 | Address change (Przy Agorze 10/47, 01-960, Warszawa → Ul. Grzybowska 87, 00-844, Warszawa) | |
| 2017-12-05 | PKD change (Removed: 46.90.Z; Added: 86.90.A) | |
| 2017-04-04 | Name change (Manomay → Amba) | |
| 2017-04-04 | PKD change (Removed: 56.30.Z, 86.90.E; Added: 46.46.Z, 46.90.Z) | |
| 2016-04-15 | PKD change (Removed: 66 codes) |
FAQ
The main business activity of Amba focuses on paramedical activities.
The company was registered in the Polish National Court Register (KRS) on April 20, 2011.
The headquarters is located at: ul. Grzybowska 87, 00-844 Warszawa.
The management board consists of: Katarzyna Maria Piłat Nałęcz (President of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
The company reported a revenue of $33,291 in 2022, which is a decrease of 2.8% compared to 2021.
Yes, the company recorded a net profit of $96 in 2022.
The largest operating cost category falls under other operating costs. This category amounted to $16,878 in 2022, representing 51% of all operating expenses.
Last updated: 2026-04-20
